Bridgewater Associates - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bridgewater Associates ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2022$873,000
+14.4%
52,412
+1.1%
0.00%
+33.3%
Q2 2022$763,000
-24.6%
51,855
+27.1%
0.00%
-25.0%
Q1 2022$1,012,000
+6.8%
40,787
+38.0%
0.00%
-33.3%
Q4 2021$948,000
-16.0%
29,560
-5.7%
0.01%0.0%
Q3 2021$1,128,00031,3520.01%
Other shareholders
PULMONX CORP shareholders Q1 2022
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 994,971$10,278,0505.54%
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$621,9072.98%
PURA VIDA INVESTMENTS, LLC 726,298$7,502,6581.42%
CFM WEALTH PARTNERS LLC 264,039$2,727,5230.71%
BRAIDWELL LP 988,559$10,211,8140.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,017,958$10,515,5060.23%
Rock Springs Capital Management LP 652,400$6,739,2920.18%
Point72 Asset Management, L.P. 2,929,903$30,265,8980.09%
ALGERT GLOBAL LLC 117,327$1,2120.06%
Campbell & CO Investment Adviser LLC 45,380$468,7750.06%
View complete list of PULMONX CORP shareholders